Haiyan Li
Welcome,         Profile    Billing    Logout  
 8 Trials 
15 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Li, Haiyan
NCT02062489: Evaluation of Tamoxifen's Efficacy for ER/PR Negative,ER-beta Positive Operable Breast Cancer Patients

Recruiting
3
688
RoW
Tamoxifen, Nolvadex, Placebo
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Breast Cancer
05/25
05/26
NCT03894163: A Phase I Study of Etrasimod in Healthy Chinese Audlt Subjects.

Recruiting
1
36
RoW
Etrasimod, Etrasimod Placebo
Everstar Therapeutics Limited
Healthy Volunteers
06/19
10/19
NCT04613999: A Study of Ralinepag in Healthy Chinese Adult Subjects

Completed
1
15
RoW
Ralinepag
Everstar Medicines (Shanghai) Limited
Healthy Volunteer, Pharmacokinetic Study
11/20
11/20
NCT06290466: Clinical Study on Pharmacokinetics of FCN-437c Capsule and Its Effect on QT Interval in Healthy Subjects

Completed
1
18
RoW
Low dose group, FCN-437c capsule or FCN-437c capsule Placebo, High dose group
Ahon Pharmaceutical Co., Ltd.
Advanced Breast Cancer
02/23
02/23
NCT05641181: A Trial of CRB4101 in Healthy Subjects

Recruiting
1
48
RoW
CRB4101, Drug intervention, Placebo, Placebo intervention
China Resources Biopharmaceutical Co., Ltd, Peking University Third Hospital
Healthy Adult Subjects
04/23
06/23
NCT06158737: A Clinical Trial Evaluated the Safety and Tolerability, Pharmacokinetic and Pharmacodynamics Profile, and Immunogenicity of a Single Dose of JS010 Injection in Healthy Subjects

Recruiting
1
48
RoW
JS010 injection, Placebo
Shanghai Junshi Bioscience Co., Ltd.
Migraine
06/24
09/24
NCT05757596: Study of VSA001 Injection in Chinese Healthy Adult Volunteers

Completed
1
24
RoW
VSA001 injection, Placebo
Visirna Therapeutics HK Limited, Arrowhead Pharmaceuticals
Healthy Adult Volunteers
09/23
12/23
NCT06132360: the Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects in Adult Subjects With Elevated LDL-C

Completed
1
32
RoW
RN0191
Shanghai Rona Therapeutics Co., Ltd., SHANGHAI RONA Therapeutics Co.,Ltd.
To Reduce the LDL-C Level in Hypercholesteremia Patients
07/24
09/24
NCT06344533: Study of JMKX003142 Injection in Chinese Healthy Subjects

Not yet recruiting
1
78
RoW
JMKX003142 Injection, Placebo
Jemincare, Zhejiang Hangyu Pharmaceutical Co., Ltd
Healthy Adult
01/25
05/25
NCT06501586: Study of SGB-3908 in Healthy Subjects and Mildly Hypertensive Subjects

Recruiting
1
48
RoW
SGB-3908, SGB-3908-Matching placebo
Suzhou Sanegene Bio Inc., Innovent Biologics (Suzhou) Co. Ltd.
Hypertension,Essential
08/25
01/26
NCT06563713: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of STSP-0902 in Healthy Subjects

Active, not recruiting
1
40
RoW
STSP-0902 injection, Placebo
Staidson (Beijing) Biopharmaceuticals Co., Ltd
Oligozoospermia, Asthenozoospermia
04/25
04/25
NCT06543459: To Evaluate the Effect of Single Oral Dose of MY008211A Tablets on QTc Interval in Healthy Subjects

Not yet recruiting
1
16
RoW
MY008211A tablets, Placebo
Wuhan Createrna Science and Technology Co., Ltd
Paroxysmal Nocturnal Hemoglobinuria
09/24
12/24
NCT06090799: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-3032 in Healthy Subjects

Completed
1
6
RoW
SHR-3032, SHR-3032 Placebo
Guangdong Hengrui Pharmaceutical Co., Ltd
Prevention of Graft Rejection After Organ Transplantation
03/24
04/24
NCT06678776: Endoscopic Anatomy of the Breast Fascia System

Recruiting
N/A
184
RoW
surgery
Haiyan Li
Breast Disease, Anatomy
12/24
12/24
Solitaire, NCT04692402: Feasibility Trial Evaluating Efficacy and Safety of â„¢ Thrombus Retrieval Device in the Management of Refractory Thrombus in Patients With Acute Coronary Syndrome

Recruiting
N/A
51
RoW
Solitaireâ„¢ thrombus retrieval device
Paul Ong
Refractory Thrombus in Patients With Acute Coronary Syndrome
06/22
09/22
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Li, Haiyan
NCT02062489: Evaluation of Tamoxifen's Efficacy for ER/PR Negative,ER-beta Positive Operable Breast Cancer Patients

Recruiting
3
688
RoW
Tamoxifen, Nolvadex, Placebo
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
Breast Cancer
05/25
05/26
NCT03894163: A Phase I Study of Etrasimod in Healthy Chinese Audlt Subjects.

Recruiting
1
36
RoW
Etrasimod, Etrasimod Placebo
Everstar Therapeutics Limited
Healthy Volunteers
06/19
10/19
NCT04613999: A Study of Ralinepag in Healthy Chinese Adult Subjects

Completed
1
15
RoW
Ralinepag
Everstar Medicines (Shanghai) Limited
Healthy Volunteer, Pharmacokinetic Study
11/20
11/20
NCT06290466: Clinical Study on Pharmacokinetics of FCN-437c Capsule and Its Effect on QT Interval in Healthy Subjects

Completed
1
18
RoW
Low dose group, FCN-437c capsule or FCN-437c capsule Placebo, High dose group
Ahon Pharmaceutical Co., Ltd.
Advanced Breast Cancer
02/23
02/23
NCT05641181: A Trial of CRB4101 in Healthy Subjects

Recruiting
1
48
RoW
CRB4101, Drug intervention, Placebo, Placebo intervention
China Resources Biopharmaceutical Co., Ltd, Peking University Third Hospital
Healthy Adult Subjects
04/23
06/23
NCT06158737: A Clinical Trial Evaluated the Safety and Tolerability, Pharmacokinetic and Pharmacodynamics Profile, and Immunogenicity of a Single Dose of JS010 Injection in Healthy Subjects

Recruiting
1
48
RoW
JS010 injection, Placebo
Shanghai Junshi Bioscience Co., Ltd.
Migraine
06/24
09/24
NCT05757596: Study of VSA001 Injection in Chinese Healthy Adult Volunteers

Completed
1
24
RoW
VSA001 injection, Placebo
Visirna Therapeutics HK Limited, Arrowhead Pharmaceuticals
Healthy Adult Volunteers
09/23
12/23
NCT06132360: the Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Effects in Adult Subjects With Elevated LDL-C

Completed
1
32
RoW
RN0191
Shanghai Rona Therapeutics Co., Ltd., SHANGHAI RONA Therapeutics Co.,Ltd.
To Reduce the LDL-C Level in Hypercholesteremia Patients
07/24
09/24
NCT06344533: Study of JMKX003142 Injection in Chinese Healthy Subjects

Not yet recruiting
1
78
RoW
JMKX003142 Injection, Placebo
Jemincare, Zhejiang Hangyu Pharmaceutical Co., Ltd
Healthy Adult
01/25
05/25
NCT06501586: Study of SGB-3908 in Healthy Subjects and Mildly Hypertensive Subjects

Recruiting
1
48
RoW
SGB-3908, SGB-3908-Matching placebo
Suzhou Sanegene Bio Inc., Innovent Biologics (Suzhou) Co. Ltd.
Hypertension,Essential
08/25
01/26
NCT06563713: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of STSP-0902 in Healthy Subjects

Active, not recruiting
1
40
RoW
STSP-0902 injection, Placebo
Staidson (Beijing) Biopharmaceuticals Co., Ltd
Oligozoospermia, Asthenozoospermia
04/25
04/25
NCT06543459: To Evaluate the Effect of Single Oral Dose of MY008211A Tablets on QTc Interval in Healthy Subjects

Not yet recruiting
1
16
RoW
MY008211A tablets, Placebo
Wuhan Createrna Science and Technology Co., Ltd
Paroxysmal Nocturnal Hemoglobinuria
09/24
12/24
NCT06090799: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of SHR-3032 in Healthy Subjects

Completed
1
6
RoW
SHR-3032, SHR-3032 Placebo
Guangdong Hengrui Pharmaceutical Co., Ltd
Prevention of Graft Rejection After Organ Transplantation
03/24
04/24
NCT06678776: Endoscopic Anatomy of the Breast Fascia System

Recruiting
N/A
184
RoW
surgery
Haiyan Li
Breast Disease, Anatomy
12/24
12/24
Solitaire, NCT04692402: Feasibility Trial Evaluating Efficacy and Safety of â„¢ Thrombus Retrieval Device in the Management of Refractory Thrombus in Patients With Acute Coronary Syndrome

Recruiting
N/A
51
RoW
Solitaireâ„¢ thrombus retrieval device
Paul Ong
Refractory Thrombus in Patients With Acute Coronary Syndrome
06/22
09/22

Download Options